TBK1 mutation spectrum in an extended European patient cohort with frontotemporal dementia and amyotrophic lateral sclerosis
We investigated the mutation spectrum of the TANK-Binding Kinase 1 (TBK1) gene and its associated phenotypic spectrum by exonic resequencing of TBK1 in a cohort of 2,538 patients with frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), or FTD plus ALS, ascertained within the European Early-Onset Dementia Consortium. We assessed pathogenicity of predicted protein-truncating mutations by measuring loss of RNA expression. Functional effect of in-frame amino acid deletions and missense mutations was further explored in vivo on protein level and in vitro by an NFκB-induced luciferas... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Journal article |
Erscheinungsdatum: | 2016 |
Verlag/Hrsg.: |
Wiley
|
Schlagwörter: | Science & Technology / Life Sciences & Biomedicine / Genetics & Heredity / TANK-Binding Kinase 1 / TBK1 / frontotemporal dementia / FTD / amyotrophic lateral sclerosis / ALS / mutations / NFkB luciferase reporter assay / LOBAR DEGENERATION / REPEAT EXPANSION / HEXANUCLEOTIDE REPEAT / ARGYROPHILIC GRAINS / DIAGNOSTIC-CRITERIA / BELGIAN COHORT / FAMILIAL ALS / C9ORF72 / DISEASE / TDP-43 / NFκB luciferase reporter assay |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28887351 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/10044/1/45933 |